| Literature DB >> 31366797 |
Takao Miwa1, Takashi Ibuka1, Noritaka Ozawa1, Tomohiko Sugiyama1, Masaya Kubota1, Kenji Imai1, Hiroyasu Sakai1, Koji Takai1, Hiroshi Araki1, Masahito Shimizu1.
Abstract
Colonic varices are usually associated with portal hypertension. Idiopathic colonic varices are extremely rare. A 68-year-old man with a positive fecal occult blood test result underwent colonoscopy. We detected idiopathic ileocolonic varices and a coexisting ascending colon polyp. While reviewing the literature, we found cases of biopsies and polypectomies resulting in significant bleeding. We herein report a case of idiopathic ileocolonic varices coexisting with a colon polyp treated successfully by endoscopy. The coexistence of colonic varices and a colorectal lesion that requires endoscopic treatment may lead to significant bleeding. During management, the development of a treatment strategy and obtaining informed consent are necessary.Entities:
Keywords: colon polyp; colonic varices; endoscopic mucosal resection; idiopathic; ileocolonic varices
Mesh:
Year: 2019 PMID: 31366797 PMCID: PMC6928513 DOI: 10.2169/internalmedicine.3131-19
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Figure 1.Total colonoscopy revealed the presence of ileocolonic varices at the terminal ileum and throughout the colon, extending from the ascending colon to the rectum, A: Terminal ileum, B: Ascending colon, C: Transverse colon, D: Descending colon, E: Sigmoid colon, F: Rectum.
Figure 2.A: Conventional endoscopy in the ascending colon shows a 12-mm polyp, existing on the colonic varices, B: Narrow-band imaging, C: Chromoendoscopy, D: Endoscopic ultrasound with a small-caliber ultrasonic probe showed 3- to 4-mm colonic varices in the submucosa.
Laboratory Data on Admission.
| <Peripheral blood> | ALT | 13 | U/L | <Serology> | |||||||||
| WBC | 5,580 | /μL | LDH | 173 | U/L | IgG | 1,197 | mg/dL | |||||
| RBC | 466×104 | /μL | ALP | 151 | U/L | IgA | 226 | mg/dL | |||||
| Hb | 14.6 | g/dL | γ-GTP | 19 | U/L | IgM | 54 | mg/dL | |||||
| Ht | 42.8 | % | ChE | 310 | U/L | CRP | 0.03 | μg/dL | |||||
| Plt | 21.6×104 | /μL | T-chol | 248 | mg/dL | Ferritin | 49.8 | μg/dL | |||||
| <Coagulation> | TG | 100 | mg/dL | M2BPGi | 0.39 | COI | |||||||
| PT | 111 | % | UA | 5.4 | mg/dL | <Viral markers> | |||||||
| PT-INR | 0.98 | BUN | 13.6 | mg/dL | HBs-Ag | (-) | |||||||
| APTT | 23 | sec | Cr | 1.1 | mg/dL | HBs-Ab | (-) | ||||||
| FIB | 258 | mg/dL | NH3 | 42 | μg/dL | HBc-Ab | (+) | ||||||
| FDP | <2.0 | μg/mL | Na | 139 | mEq/L | HBe-Ag | (-) | ||||||
| D dimer | 0.8 | μg/mL | K | 4.2 | mEq/L | HBe-Ab | (+) | ||||||
| AT III | 94 | % | Cl | 106 | mEq/L | HBV-DNA (PCR) | (-) | ||||||
| <Biochemistry> | Fe | 139 | μg/dL | HCV-Ab | (-) | ||||||||
| TP | 6.5 | g/dL | UIBC | 179 | μg/dL | CMV pp65 (C10/C11) | (-) | ||||||
| Alb | 4.2 | g/dL | Cu | 89 | μg/dL | EBV VCA-IgM Ab | <10 | × | |||||
| T-Bill | 1.9 | mg/dL | Zu | 86 | μg/dL | EBV VCA-IgG Ab | <10 | × | |||||
| D-Bill | 0.2 | mg/dL | BTR | 8.46 | EBNA | 40 | × | ||||||
| AST | 19 | U/L | AFP | 2.3 | ng/mL | ||||||||
WBC: white blood cell, RBC: red blood cell, Ht: hematocrit, Plt: platelet, PT: protorombin time, INR: international normalized ratio, APTT: active partial thromboplastin time, FIB: fibrinogen, FDP: fibrinogen degradation products, AT III: antithrombin III, TP: total protein, Alb: albumin, T-Bill: total bilirubin, D-bill: direct bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, GTP: glutamyltransferase, ChE: cholinesterase, T-chol: total cholesterol, TG: triglyceride, UA: uric acid, BUN: blood urea nitrogen, Cr: creatinine, NH3: ammonia, Na: natrium, K: kalium, Cl: chloride, Fe: ferrum, UIBC: unsaturated iron binding capacity, Cu: copper, Zu: zinc, BTR: ratio of branched-chain amino acid to tyrosine, AFP: alfa-fetoprotein, M2BPGi: mac-2 binding protein glycan isomer, HBs-Ag: hepatitis B surface antigen, HBs-Ab: hepatitis B surface antibody, HBc-Ab: hepatitis B core antibody, HBe-Ag: hepatitis B e antigen, HBe-Ab: hepatitis B e antibody, HBV-DNA: hepatitis B virus deoxyribonucleic acid, PCR: polymerase chain reaction, HCV-Ab: hepatitis C virus antibody, CMV pp65: cytomegalovirus pp65 antigenemia, EBV VCA-IgM Ab: Epstein-Barr virus-viral capsid antigen immunoglobulin M antibody, EBV VCA-IgG Ab: Epstein-Barr virus viral capsid antigen immunoglobulin G antibody, EBNA: epstein-barr virus nuclear antigen
Figure 3.A, B: Digital subtraction angiography of the superior mesenteric artery showed delayed venous pooling in the ascending colon. C, D: Computed tomography during superior mesenteric angiography showed the development of colonic varices in the ascending colon.
Characteristics of 33 Cases of Idiopathic Colonic Varices.
| No. | Age | Sex | Location | Family | Symptom | Treatment | Prognosis | Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 71 | F | colonic | ND | asymptomatic | none | stable | [30] | ||||||||
| 2 | 76 | M | colonic | ND | hematochezia | preserved | stable | [29] | ||||||||
| 3 | 37 | M | ileocolonic | ND | hematochezia | preserved (ARB) | disappeared | [28] | ||||||||
| 4 | 54 | M | ileocolonic | none | asymptomatic | none | stable | [27] | ||||||||
| 5 | 38 | F | colonic | none | diarrhea | none | stable | [26] | ||||||||
| 6 | ND | ND | ND | (+) | ND | ND | ND | [25] | ||||||||
| 7 | ND | ND | ND | (+) | ND | ND | ND | [25] | ||||||||
| 8 | ND | ND | ND | (+) | ND | ND | ND | [25] | ||||||||
| 9 | 30 | M | colonic | none | hematochezia, diarrhea | preserved | stable | [24] | ||||||||
| 10 | 44 | M | colonic | none | hematochezia | preserved | stable | [23] | ||||||||
| 11 | 20 | F | ileocolonic | ND | hematochezia | operation | stable | [22] | ||||||||
| 12 | 21 | M | ileocolonic | none | hematochezia | operation | stable | [21] | ||||||||
| 13 | 61 | F | colonic | (+) | hematochezia, diarrhea | preserved | stable | [20] | ||||||||
| 14 | 43 | M | colonic | none | hematochezia | preserved (propranolol) | decreased | [19] | ||||||||
| 15 | 24 | M | rectum-descending | none | hematochezia | operation | stable | [18] | ||||||||
| 16 | 74 | F | colonic | ND | hematochezia | preserved | stable | [17] | ||||||||
| 17 | 64 | ND | ileocolonic | ND | hematochezia | operation | stable | [16] | ||||||||
| 18 | ND | ND | ND | ND | ND | ND | ND | [15] | ||||||||
| 19 | ND | ND | ND | ND | ND | ND | ND | [14] | ||||||||
| 20 | 30 | M | hepatic flexure | ND | hematochezia | preserved | ND | [13] | ||||||||
| 21 | 37 | M | sigmoid | ND | hematochezia | operation | stable | [12] | ||||||||
| 22 | ND | ND | ND | ND | ND | ND | ND | [11] | ||||||||
| 23 | 27 | M | ND | ND | hematochezia | preserved | stable | [10] | ||||||||
| 24 | 56 | M | ND | (+) | ND | ND | ND | [9] | ||||||||
| 25 | 28 | M | ND | (+) | ND | ND | ND | [9] | ||||||||
| 26 | 81 | M | ND | ND | hematochezia | ND | ND | [8] | ||||||||
| 27 | 32 | M | rectum-sigmoid | none | hematochezia | operation | stable | [7] | ||||||||
| 28 | 25 | M | ileocolonic | ND | hematochezia | preserved | stable | [6] | ||||||||
| 29 | ND | ND | colonic | ND | ND | ND | ND | [5] | ||||||||
| 30 | 58 | M | rectum-sigmoid, caecum | none | hematochezia | preserved | stable | [4] | ||||||||
| 31 | ND | ND | colonic | none | hematochezia | operation | stable | [3] | ||||||||
| 32 | ND | ND | colonic | ND | ND | ND | ND | [2] | ||||||||
| 33 | ND | ND | colonic | ND | ND | ND | ND | [2] |
ND: Not detected, ARB: Angiotensin receptor blocker